Success Stories: We Fully Supported a Visiting Researcher Scholar in the Field of Bioengineering from China to Successfully Secure NIW Approval, Despite RFE

Posted by wegreened on February 11, 2023 in NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“I am kind of anxious when I began to consult if I can apply green card via my visiting researcher status. After a prompt evaluation of my researching achievement, the team of North America Immigration Law Group gave me a professional suggestion for NIW category. Even though I got a RFE for petition of the first round, I am peaceful and confident in the successfully secure NIW Approval under the professional help of the team. I and my family really appreciated it.”

On September 20^th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Visiting Researcher Scholar in the field of Bioengineering (Approval Notice).

General Field: Bioengineering

Position at the Time of Case Filing: Visiting Researcher Scholar

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: September 20^th, 2021

Processing Time: 12 months, 12 days

Case Summary:

A Visiting Researcher Scholar, having obtained an MD in clinical medicine hired North America Immigration Law Group to help him obtain an I-140 NIW (National Interest Waiver) petition approval. Our law firm is well established for filing visa petitions precisely which assists our clients to achieve their ultimate goals; their green cards. Thus, before moving forward to prepare his NIW petition packet, we properly evaluated his credentials so that we could be certain of making him secure his NIW approval. We made sure to file a successful application in his category.

Here is the outline of his NIW petition packet, incorporating the following details:

We briefed his research focusing on utilizing novel bioengineering devices to improve surgical methods for treating degenerative spine diseases to reduce the impact of spine diseases on health outcomes. Specifically, his research looks into how spinal injuries progress into chronic back pain and is creating a novel lumbar spinal injury model and applying advanced biomechanical and animal models to evaluate the pathomechanisms of low back pain.
We showcased how his research has great substantial merit and national importance as among other applicants, his research is relevant to reducing the economic burden and rate of disability associated with degenerative spinal diseases in the United States and around the world. His research provides a platform for the development of improved therapies and diagnostic methods for spinal diseases, which are a major burden on healthcare and economic productivity.

We focused on his splendid publications, citations, and patent records:

23 peer-reviewed journal and conference articles (9 of them first-authored) and 1 book, published in top journals in the field of bioengineering.
63 times cited according to Google Scholar, serving as a testament to its high quality and relevance to ongoing research.
2 Chinese invention patents and 3 Chinese utility patents
We even noticed that our client has been regularly invited to conduct peer reviews for elite journals in the field and has completed at least 31 reviews to date.

All the above factors, his consistent record of success, and his myriad professional accomplishments, therefore, made it clear that our client is seen as very knowledgeable in his field of expertise.

Moreover, to establish the fact that our client is at the front line in his field, we attached 5 recommendation letters provided by him obtained from other experts in the field. Two of the recommenders had the following to say about him:

“[Client’s] new method for the treatment of osteoporotic vertebral compression fractures is especially important to American public health…The prevalence of osteoporosis, particularly as Americans continue to age, will continue to increase…Therefore, further research into more advanced diagnostic methods and treatments is essential. [Client’s] continued bioengineering research into this subject will be [an] important contributor to the U.S. scientific community.”

“In addition, I would like to discuss the overall importance of [client’s] research in more detail. His work on developing new diagnostic methods and treatments for patients with lumbar conditions is directly relevant to improving public health outcomes in the United States…[Client’s] improved microendoscopic discectomy procedure helps surgeons avoid complications, and thus helps improve overall patient outcomes.”

In addition to the above excerpts, our client’s research has even received funding from major institutions including the Province Commission of Health which is highly selective and thus further corroborates the practical utility of his work for advancing the technological and healthcare capacities of clinicians around the world.

Lastly, his consistent patience throughout the process finally culminated with good news as despite requesting further evidence [RFE] and waiting for a longer duration, the USCIS eventually granted our client the I-140 NIW approval with our consistent encouragement. We are glad that our client found us, and we were able to lend him help to achieve the NIW approval. We sincerely thank our client for trusting our firm and wish him good luck in the future.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%